共 50 条
- [2] Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (05): : 1159 - 1167
- [9] Endocan predicts development of HCC in patients with compensated cirrhosis, portal hypertension and no varices [J]. FEBS OPEN BIO, 2019, 9 : 73 - 73